Clinical Trial

Mobile Health Intervention for Children With Autism

Study acronym: WeChat-Autism
Completed
View on ClinicalTrials.gov →
Summary
This study is a randomized clinical trial conducted in China from January 2023 to July 2025. It aims to test whether a mobile health program delivered via WeChat, with or without additional human support, can help improve body weight outcomes in children with autism. Children aged 8 to 16 years with autism were randomly assigned to one of three groups: (1) usual care, (2) a 16-week WeChat-based lifestyle intervention, or (3) the same WeChat intervention plus weekly tele-group sessions led by a coach. The main outcome is the change in body mass index (BMI) z-score after 16 weeks. Secondary outcomes include the development of obesity over 6, 12, and 24 months, as well as changes in physical activity, screen time, eating habits, and other health behaviors. A total of 276 families participated. The results will help understand whether digital health programs can be an effective and scalable option for supporting healthy lifestyles in children with autism.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-31.
Trial Details
NCT Number NCT07514910
Lead Sponsor Hunan Normal University
Conditions Autism Spectrum Disorder, Obesity, Pediatric Overweight
Enrollment 276 participants
Start Date 2023-01-01
Primary Completion 2025-07-01 (estimated)
Study Completion 2025-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-13